Niedzwiecki D - Search Results

1

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.

Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM. Morse MA, et al. Among authors: niedzwiecki d. J Transl Med. 2007 Sep 6;5:42. doi: 10.1186/1479-5876-5-42. J Transl Med. 2007. PMID: 17822557 Free PMC article. Clinical Trial.

2

Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.

Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Cumming RI, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly HK. Morse MA, et al. Among authors: niedzwiecki d. J Clin Oncol. 2000 Dec 1;18(23):3883-93. doi: 10.1200/JCO.2000.18.23.3883. J Clin Oncol. 2000. PMID: 11099317 Clinical Trial.

3

Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis.

Hobeika AC, Morse MA, Osada T, Ghanayem M, Niedzwiecki D, Barrier R, Lyerly HK, Clay TM. Hobeika AC, et al. Among authors: niedzwiecki d. J Immunother. 2005 Jan-Feb;28(1):63-72. doi: 10.1097/00002371-200501000-00008. J Immunother. 2005. PMID: 15614046

4

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.

Su Z, Dannull J, Yang BK, Dahm P, Coleman D, Yancey D, Sichi S, Niedzwiecki D, Boczkowski D, Gilboa E, Vieweg J. Su Z, et al. Among authors: niedzwiecki d. J Immunol. 2005 Mar 15;174(6):3798-807. doi: 10.4049/jimmunol.174.6.3798. J Immunol. 2005. PMID: 15749921

5

Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.

Morse MA, Clay TM, Hobeika AC, Osada T, Khan S, Chui S, Niedzwiecki D, Panicali D, Schlom J, Lyerly HK. Morse MA, et al. Among authors: niedzwiecki d. Clin Cancer Res. 2005 Apr 15;11(8):3017-24. doi: 10.1158/1078-0432.CCR-04-2172. Clin Cancer Res. 2005. PMID: 15837756 Clinical Trial.

6

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.

Vredenburgh JJ, Madan B, Coniglio D, Ross M, Broadwater G, Niedzwiecki D, Edwards J, Marks L, Vandemark R, McDonald C, Affronti ML, Peters WP. Vredenburgh JJ, et al. Among authors: niedzwiecki d. Bone Marrow Transplant. 2006 Jun;37(11):1009-15. doi: 10.1038/sj.bmt.1705367. Bone Marrow Transplant. 2006. PMID: 16633363 Clinical Trial.

7

Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.

Hobeika A, Osada T, Serra D, Peplinski S, Hanson K, Tanaka Y, Niedzwiecki D, Chao N, Rizzieri D, Lyerly H, Clay T, Morse M. Hobeika A, et al. Among authors: niedzwiecki d. Cytotherapy. 2008;10(3):289-302. doi: 10.1080/14653240801927040. Cytotherapy. 2008. PMID: 18418774

8

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

Morse MA, Hobeika AC, Osada T, Serra D, Niedzwiecki D, Lyerly HK, Clay TM. Morse MA, et al. Among authors: niedzwiecki d. Blood. 2008 Aug 1;112(3):610-8. doi: 10.1182/blood-2008-01-135319. Epub 2008 Jun 2. Blood. 2008. PMID: 18519811 Free PMC article. Clinical Trial.

9

Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.

Reddy SK, Broadwater G, Niedzwiecki D, Barbas AS, Hurwitz HI, Bendell JC, Morse MA, Clary BM. Reddy SK, et al. Among authors: niedzwiecki d. J Gastrointest Surg. 2009 Jan;13(1):74-84. doi: 10.1007/s11605-008-0617-5. Epub 2008 Aug 7. J Gastrointest Surg. 2009. PMID: 18685900

10

Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.

Osada T, Yang XY, Hartman ZC, Glass O, Hodges BL, Niedzwiecki D, Morse MA, Lyerly HK, Amalfitano A, Clay TM. Osada T, et al. Among authors: niedzwiecki d. Cancer Gene Ther. 2009 Sep;16(9):673-82. doi: 10.1038/cgt.2009.17. Epub 2009 Feb 20. Cancer Gene Ther. 2009. PMID: 19229288 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters